Lv43
430 积分 2020-08-28 加入
The past, present, and future of immunotherapy for colorectal cancer
7天前
已完结
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
16天前
已完结
Salvage surgery following downstaging of unresectable hepatocellular carcinoma--a strategy to increase resectability
17天前
已完结
A new strategy for immunotherapy of microsatellite-stable (MSS)-type advanced colorectal cancer: Multi-pathway combination therapy with PD-1/PD-L1 inhibitors
17天前
已完结
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
18天前
已完结
复发难治性实体瘤NTRK靶向治疗新策略
24天前
已完结
BRAF抑制剂治疗恶性实体肿瘤专家共识（2024版）
25天前
已完结
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
1个月前
已完结
低级别卵巢浆液性癌诊治的研究进展
1个月前
已完结
皖公网安备34019202002308
